China puts Dajia Insurance on the auction block for US$5.2bn
July 19 2021 by Gloria Zhou
-
China’s ZhongAn’s operating performance is subject to investment volatility, business risk: AM Best
- November 11
The rating agency affirms financial strength rating of A- (excellent) and long-term issuer credit rating of “a-” (excellent) to the carrier with a stable outlook.
-
Sinosure limits trade credit insurance for exports to Russia: report
- November 8
The Chinese state-owned carrier has reportedly started refusing to insure supplies against the risk of non-payment to Russia fearing payment disruptions and secondary sanctions.
-
APAC 9M economic losses from nat cats topped US$70bn: Aon
- October 29
The damage from the first nine months of the year is higher than the US$69.6bn in economic losses caused by natural perils for the whole of last year.
-
China launches new insurance scheme to support cross-border commerce: report
- October 24
Insurance companies can offer tariff guarantees for cross-border businesses, eliminating the need for them to use physical collateral or pay large tariff deposits to banks.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
